Celltrion Seo Jung-jin
Scope
Date
~
-
Bio & Pharma
Celltrion establishes subsidiary in Vietnam
Celltrion Inc., South Korea’s largest biosimilar maker, said on Monday that it completed the establishment of a local subsidiary in Vietnam....
Sep 30, 2024 (Gmt+09:00)
-
Airlines
Jin Air to expand SE Asia, Oceania routes
South Korea's budget carrier Jin Air said on Friday that it will resume and expand its international flights for the upcoming winter season, focus...
Sep 27, 2024 (Gmt+09:00)
-
K-pop
HYBE shares fall after NewJeans demand Min's reinstatement
HYBE Co. has suffered a fall of its share price for two consecutive days after its popular girl group NewJeans demanded their former creative direct...
Sep 13, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion to supply breast, stomach cancer treatment to Brazil
Celltrion Inc., South Korea’s largest biosimilar maker, announced on Friday that its breast and stomach cancer treatment "Herzuma" (active ing...
Sep 13, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion earmarks billions of dollars to build CDMO plant: chairman
Celltrion Inc., South Korea’s largest biosimilar maker, will spend several billion dollars to build a factory to crack the contract developmen...
Sep 11, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion chairman announces venture into CDMO market
South Korea’s biosimilar maker Celltrion Inc. will venture into the contract development and manufacturing organization (CDMO) market, the com...
Sep 09, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion scraps merger with Celltrion Pharm
South Korea’s largest biosimilar maker Celltrion Inc. said on Friday that it has scrapped a plan to merge with Celltrion Pharm Inc., an R&...
Aug 16, 2024 (Gmt+09:00)
-
Bio & Pharma
Costco sells Celltrion's Yuflyma Low WAC in US
South Korea's Celltrion Inc. announced on Tuesday that its autoimmune disease treatment Yuflyma (Low WAC, active ingredient adalimumab) is now avail...
Aug 13, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion gets FDA nod for Keytruda copy's phase 3 clinical trials
Celltrion Inc., South Korea’s biosimilar giant, will proceed with phase 3 trials for global blockbuster drug Keytruda’s copycat CT-P51, ...
Aug 12, 2024 (Gmt+09:00)
-
Korean stock market
Biotech stocks, foreigners’ top pick in Korea amid panic selling
Foreigners and institutional investors in the South Korean stock market picked biotechs as their favorite shares in hopes of a biopharma stock jump ...
Aug 11, 2024 (Gmt+09:00)
-
Airlines
Jin Air to launch daily flights on Busan-Nagoya route
South Korea's low-cost carrier Jin Air announced on Friday that it will launch a new route between Busan and Nagoya, starting on Sept. 14, with dail...
Aug 09, 2024 (Gmt+09:00)
-
Korean games
PUBG’s Krafton taps ex-Apple, Samsung execs for global business
South Korean gaming giant Krafton Inc. has hired former executives of not only global game developers but also tech leaders such as Apple Inc. and S...
Aug 07, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion's Zymfentra joins US insurance-covered drug lists
South Korean biosimilar maker Celltrion Inc. said on Monday that its subcutaneous injection formulation for autoimmune diseases, Zymfentra (inflixim...
Aug 06, 2024 (Gmt+09:00)
-
Airlines
Jeju Air seeks M&A, igniting race for top place in Korea's LCC market
Jeju Air Co., a leading South Korean low-cost carrier (LCC), will likely seek the acquisition and merger of a rival small airline operator amid inte...
Aug 02, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion gets approval of Steqeyma in Canada
South Korea’s Celltrion Inc., received new drug submission (NDS) approval from Health Canada for Steqeyma, a biosimilar of the autoimmune dise...
Jul 31, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion’s new plant in Songdo poised for commercial production
South Korea’s largest biosimilar maker Celltrion Inc. said on Tuesday that its third plant in Sondgo, west of Seoul, is undergoing process val...
Jul 23, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion's Remsima SC breaks 20% market share in Europe
South Korea's biopharmaceutical company Celltrion Inc. said on Wednesday that its subcutaneous autoimmune disease treatment Remsima SC has surpassed...
Jul 17, 2024 (Gmt+09:00)
-
Airlines
Jin Air earns Sustinvest ESG A grade
South Korea's low-cost carrier (LCC) Jin Air announced on Wednesday that it received an A in the Sustinvest ESG (Environmental, Social, Governance) ...
Jun 26, 2024 (Gmt+09:00)
-
Pension funds
Korea's NPS CIO talks with GPIF, GIC execs on asset allocation
South Korea’s National Pension Service (NPS) Chief Investment Officer Seo Won-joo has visited Japan and Singapore on his first overseas busine...
Jun 24, 2024 (Gmt+09:00)
-
Korean food
KGC enters Malaysian healty functional food market
Korea Ginseng Corp. (KGC), wholly owned by South Korean tobacco giant KT&G Corp., announced on June 13 that it sells its red ginseng brand Jung ...
Jun 14, 2024 (Gmt+09:00)
-
K-pop
ADOR CEO behind NewJeans stays with HYBE after court win
A legal battle between South Korea’s entertainment powerhouse HYBE Co. and the chief of its sublabel ADOR will likely drag on as the internati...
May 30, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion eyes M&A in Europe, $3.3 bn Zymfentra sales: chairman
WASHINGTON, D.C. – South Korean biosimilar giant Celltrion Inc. is accelerating its push to transform into a novel drug developer, going after...
May 23, 2024 (Gmt+09:00)
-
Airlines
Jin Air to resume Incheon-Hong Kong route in July
South Korea's low-cost carrier Jin Air announced on Friday that it will resume flights on the Incheon to Hong Kong route on July 18.This marks the r...
May 10, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion to supply Remsima, Herzuma to Peru
South Korea's Celltrion Inc. announced on Thursday that it secured a contract to supply its biosimilars for autoimmune disease treatment and antican...
May 02, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion releases Remsima SC in Denmark
South Korea's Celltrion Inc. announced on Thursday that it released its autoimmune disease treatment Remsima SC (infliximab) in Denmark. Remsima SC ...
Apr 19, 2024 (Gmt+09:00)
-
Bio & Pharma
Korea’s Celltrion, SK Biopharmaceuticals benefit from direct US sales
Celltrion Inc. and SK Biopharmaceuticals Co. are witnessing improving sales revenue and profitability by selling their products through their own ma...
Apr 16, 2024 (Gmt+09:00)
-
Markets
Samsung heiress sells $326 mn worth of Samsung Elec shares
Samsung Group heiress and Hotel Shilla Chief Executive Lee Boo-jin sold 441.2 billion won ($325.9 million) worth of Samsung Electronics Co. shares i...
Apr 09, 2024 (Gmt+09:00)
-
Real estate
Shinhan to build landmark office tower for non-banking units
Shinhan Financial Group Co., South Korea's second-largest financial group, plans to build a new high-rise office tower in Seoul’s central busi...
Mar 25, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion'a autoimmune disease drug Zymfentra makes US debut
South Korean biopharmaceutical giant Celltrion Inc. said on March 17 that it has launched its new autoimmune disease treatment Zymfentra in the US m...
Mar 18, 2024 (Gmt+09:00)
-
Airlines
Jin Air offers up to 15% discount on Japan routes
South Korea's low-cost carrier Jin Air announced on Friday that it will offer various benefits to passengers on its Japan routes until Mar. 24.Jin A...
Mar 08, 2024 (Gmt+09:00)
Latest News
- 1 Hyundai, Waymo forge multi-year, strategic partnership for self-driving vehicles
- 2 AI startup MarqVision raises $16.5 mn to close Series A
- 3 Taihan Cable wins $630 mn power grid project in Singapore
- 4 Korean startup scene is gloomy, say 2 out of 5 startup CEOs
- 5 MBK ups stakes for Korea Zinc to match buyback offer